SCHEMBL5667451

SCHEMBL5667451

NCCCCCCNNN

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.48
CA2 P00918 4/20 0.48
CA4 P22748 4/20 0.48
CA6 P23280 4/20 0.48
CA5A P35218 4/20 0.48
CA7 P43166 4/20 0.48
CA9 Q16790 4/20 0.48
CA14 Q9ULX7 4/20 0.48
CA5B Q9Y2D0 4/20 0.48
CA1 P00915 3/20 0.48
CA3 P07451 3/20 0.48
TSHR P16473 2/20 0.48
F13A1 P00488 2/20 0.48
CYP1A2 P05177 2/20 0.48
ALOX15 P16050 2/20 0.48
THPO P40225 2/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
MTOR P42345 1/20 0.48
LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9066384 1.00 CA12 (0.48) CA12CA2CA4CA6CA5A
SCHEMBL5701081 1.00 CA12 (0.48) CA12CA2CA4CA6CA5A
SCHEMBL15599702 0.88
SCHEMBL11197509 0.84 CA12 (0.57) CA12CA2CA4CA6CA5A
SCHEMBL7875353 0.81 CA12 (0.61) CA12CA2CA4CA6CA5A
SCHEMBL29392150 0.81 CA12 (0.65) CA12CA2CA4CA6CA5A
SCHEMBL9302932 0.81 CA12 (0.42) CA12CA2CA4CA6CA5A
SCHEMBL6016766 0.75 CA12 (0.53) CA12CA2CA4CA6CA5A
SCHEMBL16616240 0.75 CA12 (0.53) CA12CA2CA4CA6CA5A
SCHEMBL680005 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210145004-A1 SURFACE, AIR, TEXTILE, PAINT, PLASTIC, SILICONE AND WOOD, POLYETHYLENE; METAL AND DERIVATIVES ANTIMICROBIAL PROPERTIES UCAR HEALTH GMBH (DE) 2021-05-20 US disclosed
US-10307313-B2 Equipment mounting system FERNO-WASHINGTON, INC. (US) 2019-06-04 US disclosed
US-20170209318-A1 EQUIPMENT MOUNTING SYSTEM FERNO-WASHINGTON, INC. (US) 2017-07-27 US disclosed
EP-2500018-A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure PhilERA New Zealand Limited (NZ) 2012-09-19 EP disclosed
EP-1487431-A4 PREVENTING AND/OR TREATING CARDIOVASCULAR DISEASE AND/OR ASSOCIATED HEART FAILURE PROTEMIX CORP LTD (NZ) 2006-10-25 EP disclosed
EP-1487431-A1 PREVENTING AND/OR TREATING CARDIOVASCULAR DISEASE AND/OR ASSOCIATED HEART FAILURE Protemix Corporation Limited (NZ) 2004-12-22 EP disclosed
WO-2003077901-A1 PREVENTING AND/OR TREATING CARDIOVASCULAR DISEASE AND/OR ASSOCIATED HEART FAILURE PROTEMIX CORPORATION LIMITED (NZ) 2003-09-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210145004-A1 SURFACE, AIR, TEXTILE, PAINT, PLASTIC, SILICONE AND WOOD, POLYETHYLENE; METAL AND DERIVATIVES ANTIMICROBIAL PROPERTIES CTSA, CUTA, LCT CA12 793/4885CA2 321/4885CA4 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.